Comparative Effectiveness and Safety Between Endoscopic Sleeve Gastroplasty and Laparoscopic Sleeve Gastrectomy: a Meta-analysis of 6775 Individuals with Obesity.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
11 2022
Historique:
received: 03 05 2022
accepted: 19 08 2022
revised: 09 08 2022
pubmed: 3 9 2022
medline: 1 11 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

Endoscopic sleeve gastroplasty (ESG) is a novel endoscopic bariatric therapy that complements current medical and surgical therapeutic offerings for weight management and fills an unmet need. Few meta-analyses compared ESG to laparoscopic sleeve gastrectomy (LSG). However, these studies relied on indirect evidence derived from non-comparative studies. Comparative effectiveness data derived from direct comparative studies is needed. We performed a meta-analysis of studies that directly compared ESG with LSG. A comprehensive search of PubMed, Embase, and Cochrane databases was conducted. Single-arm studies were excluded. Pooled mean difference (MD) and risk ratio (RR) with 95% confidence intervals (CIs) were obtained within a random-effect model. Seven studies with 6,775 patients (3,413 with ESG vs. 3,362 with LSG) were included. There were significant differences in 6-month (MD - 7.48; 95% CI - 10.44, - 4.52; P < 0.00001), 12-month (MD - 9.90; 95% CI - 10.59, - 9.22; P < 0.00001), and 24-month (MD - 7.63; 95% CI - 11.31, - 3.94; P < 0.0001) TBWL% favoring LSG over ESG. There was a trend toward lower incidence of adverse events with ESG compared to LSG but did not reach statistical significance (RR 0.51, 95% CI 0.23-1.11, P = 0.09). The incidence of new-onset gastroesophageal reflux disease (GERD) was significantly lower after ESG compared to LSG, 1.3% vs. 17.9%, respectively (RR 0.10, 95% CI 0.02-0.53, P = 0.006). ESG achieved clinically adequate but lower short- and mid-term weight loss when compared to LSG, with fewer adverse events, including GERD. Given the stomach-sparing nature of ESG and acceptable safety profile, it provides an acceptable alternative to LSG for patients with mild-to-moderate obesity.

Identifiants

pubmed: 36053446
doi: 10.1007/s11695-022-06254-y
pii: 10.1007/s11695-022-06254-y
doi:

Types de publication

Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3504-3512

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012;31:219–30.
doi: 10.1016/j.jhealeco.2011.10.003 pubmed: 22094013
Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307:491–7.
doi: 10.1001/jama.2012.39 pubmed: 22253363
World Health Organization. Obesity and overweight. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight . Accessed December 6, 2019.
Pi-Sunyer X. The medical risks of obesity. Postgrad Med. 2009;121:21–33.
doi: 10.3810/pgm.2009.11.2074 pubmed: 19940414 pmcid: 2879283
Cochrane AJ, Dick B, King NA, et al. Developing dimensions for a multicomponent multidisciplinary approach to obesity management: a qualitative study. BMC Public Health. 2017;17:814.
doi: 10.1186/s12889-017-4834-2 pubmed: 29037238 pmcid: 5644160
A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis. 2011;7:672–82.
English WJ, DeMaria EJ, Brethauer SA, et al. American Society for Metabolic and Bariatric Surgery estimation of metabolic and bariatric procedures performed in the United States in 2016. Surg Obes Relat Dis. 2018;14:259–63.
doi: 10.1016/j.soard.2017.12.013 pubmed: 29370995
Kheirvari M, Dadkhah Nikroo N, Jaafarinejad H, et al. The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review. Heliyon. 2020;6:e03496.
doi: 10.1016/j.heliyon.2020.e03496 pubmed: 32154399 pmcid: 7052082
Qumseya BJ, Qumsiyeh Y, Ponniah SA, et al. Barrett’s esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93:343-352.e2.
doi: 10.1016/j.gie.2020.08.008 pubmed: 32798535
Yeung KTD, Penney N, Ashrafian L, et al. Does sleeve gastrectomy expose the distal esophagus to severe reflux?: a systematic review and meta-analysis. Ann Surg. 2020;271:257–65.
doi: 10.1097/SLA.0000000000003275 pubmed: 30921053
Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013;78:530–5.
doi: 10.1016/j.gie.2013.04.197 pubmed: 23711556
Abu Dayyeh BK, Acosta A, Camilleri M, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017;15:37-43.e1.
doi: 10.1016/j.cgh.2015.12.030 pubmed: 26748219
Alqahtani A, Al-Darwish A, Mahmoud AE, et al. Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc. 2019;89:1132–8.
doi: 10.1016/j.gie.2018.12.012 pubmed: 30578757
Fayad L, Adam A, Schweitzer M, et al. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc. 2019;89:782–8.
doi: 10.1016/j.gie.2018.08.030 pubmed: 30148991
Hedjoudje A, Abu Dayyeh BK, Cheskin LJ, et al. Efficacy and safety of endoscopic sleeve gastroplasty: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2020;18:1043-1053.e4.
doi: 10.1016/j.cgh.2019.08.022 pubmed: 31442601
Mohan BP, Asokkumar R, Khan SR, et al. Outcomes of endoscopic sleeve gastroplasty; how does it compare to laparoscopic sleeve gastrectomy? A systematic review and meta-analysis. Endosc Int Open. 2020;8:E558–65.
doi: 10.1055/a-1120-8350 pubmed: 32258380 pmcid: 7089787
Jalal MA, Cheng Q, Edye MB. Systematic review and meta-analysis of endoscopic sleeve gastroplasty with comparison to laparoscopic sleeve gastrectomy. Obes Surg. 2020;30:2754–62.
doi: 10.1007/s11695-020-04591-4 pubmed: 32304011
Marincola G, Gallo C, Hassan C, et al. Laparoscopic sleeve gastrectomy versus endoscopic sleeve gastroplasty: a systematic review and meta-analysis. Endosc Int Open. 2021;9:E87-e95.
doi: 10.1055/a-1300-1085 pubmed: 33403240 pmcid: 7775813
Carr P, Keighley T, Petocz P, et al. Efficacy and safety of endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy with 12+ months of adjuvant multidisciplinary support. BMC Prim Care. 2022;23:26.
doi: 10.1186/s12875-022-01629-7 pubmed: 35123409 pmcid: 8817771
Alqahtani AR, Elahmedi M, Aldarwish A, Abdurabu HY, Alqahtani S. Endoscopic gastroplasty versus laparoscopic sleeve gastrectomy: a noninferiority propensity score-matched comparative study. Gastrointest Endosc. 2022;96(1):44–50. https://doi.org/10.1016/j.gie.2022.02.050 .
doi: 10.1016/j.gie.2022.02.050 pubmed: 35248571
Lopez-Nava G, Asokkumar R, Bautista-Castaño I, et al. Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic greater curve plication: do they differ at 2 years? Endoscopy. 2021;53:235–43.
doi: 10.1055/a-1224-7231 pubmed: 32698234
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
doi: 10.1136/bmj.n71 pubmed: 33782057 pmcid: 8005924
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.
doi: 10.1001/jama.283.15.2008 pubmed: 10789670
Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785–805.
doi: 10.1177/0962280216669183 pubmed: 27683581
Borenstein M, Hedges LV, Higgins JP, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97–111.
doi: 10.1002/jrsm.12 pubmed: 26061376
Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
doi: 10.1136/bmj.327.7414.557 pubmed: 12958120 pmcid: 192859
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.
doi: 10.1007/s10654-010-9491-z pubmed: 20652370
Fiorillo C, Quero G, Vix M, et al. 6-Month gastrointestinal quality of life (QoL) results after endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a propensity score analysis. Obes Surg. 2020;30:1944–51.
doi: 10.1007/s11695-020-04419-1 pubmed: 31965488
Lopez-Nava G, Negi A, Bautista-Castaño I, et al. Gut and metabolic hormones changes after endoscopic sleeve gastroplasty (ESG) vs. laparoscopic sleeve gastrectomy (LSG). Obes Surg. 2020;30:2642–51.
doi: 10.1007/s11695-020-04541-0 pubmed: 32193741
Novikov AA, Afaneh C, Saumoy M, et al. Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic band for weight loss: how do they compare? J Gastrointest Surg. 2018;22:267–73.
doi: 10.1007/s11605-017-3615-7 pubmed: 29110192
Sullivan S, Kumar N, Edmundowicz SA, et al. ASGE position statement on endoscopic bariatric therapies in clinical practice. Gastrointest Endosc. 2015;82:767–72.
doi: 10.1016/j.gie.2015.06.038 pubmed: 26282949
Sinclair P, Brennan DJ, le Roux CW. Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer. Nat Rev Gastroenterol Hepatol. 2018;15:606–24.
doi: 10.1038/s41575-018-0057-y pubmed: 30181611
Khidir N, Al Dhaheri M, El Ansari W, et al. Outcomes of laparoscopic gastric greater curvature plication in morbidly obese patients. J Obes. 2017;2017:7989714–7989714.
doi: 10.1155/2017/7989714 pubmed: 28900545 pmcid: 5576404
Dayyeh BA, Rizk M, El-Mohsen MA, et al. Laparoscopic greater curvature plication (LGCP) vs. endoscopic sleeve gastroplasty (ESG): similar efficacy with different physiology. Surg Obes Relat Dis. 2017;13:S205.
doi: 10.1016/j.soard.2017.09.457

Auteurs

Azizullah Beran (A)

Divison of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN, 46202, USA.

Reem Matar (R)

St George's University of London, London, SW17 0RE, UK.
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Veeravich Jaruvongvanich (V)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Babusai B Rapaka (BB)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Abdullah Alalwan (A)

Department of Surgery, University of Toledo, Toledo, OH, 43606, USA.

Ray Portela (R)

Department of Surgery, Mayo Clinic, Rochester, MN, 55905, USA.

Omar Ghanem (O)

Department of Surgery, Mayo Clinic, Rochester, MN, 55905, USA.

Barham K Abu Dayyeh (BKA)

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. AbuDayyeh.Barham@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH